AcceleTrial

AcceleTrial, developed by LINEA System, is a cloud-based Study Start-Up System (SSUS) designed to streamline and automate the study start-up process for clinical trials. This solution is targeted at a range of businesses, including "Top 5" Pharma companies, mid-tier pharmaceutical companies, small start-up biotech companies, and clinical research organizations (CROs). AcceleTrial is utilized by professionals in the pharmaceutical and biotech industries, as well as clinical trial management professionals and clinical research site coordinators.

Key Features

Site Identification: According to the vendor, AcceleTrial utilizes objective and subjective data, along with proprietary algorithms, to identify qualified sites for clinical trials, with the aim of achieving optimal sponsor and site satisfaction.

Feasibility Questionnaire: The vendor states that sponsors can access real-time responses to feasibility questionnaires, which can help streamline the process of assessing a site's capability to conduct a trial.

Site Visit: AcceleTrial helps schedule and streamline Pre-Study Site Visits and Site Initiation Visits, aiming to ensure efficient site qualification and training.

Clinical Trial Agreement: The platform is designed to expedite the negotiation and initiation of clinical trial agreements, with the goal of accelerating patient enrollment.

Regulatory / IRB: AcceleTrial provides a centralized platform to view regulatory essential documents and manage IRB/Ethics approvals, which is intended to ensure compliance and expedite the approval process.

Drug Shipment: Sponsors can use AcceleTrial to monitor drug request and shipment processes, aiming to ensure timely delivery to sites and reduce delays in patient enrollment.

Enrollment: According to the vendor, AcceleTrial allows sponsors to track screening and enrollment activities in real-time, which can improve study timelines and confirm study activation.

CDA (Confidential Disclosure Agreement): The platform is designed to simplify the process of Confidential Disclosure Agreement (CDA) with auto-fills and digital signature capabilities, aiming to ensure secure and efficient exchange of confidential information.

Qualification: AcceleTrial streamlines the site qualification process by providing a platform to submit required documents and coordinate sponsor visits, with the goal of saving time and improving accuracy.

AcceleTrial Database: According to the vendor, the platform offers access to a database of thousands of qualified investigators and sites, which is intended to enhance the success and efficiency of clinical trials.